EC Number   |
Activating Compound |
Reference |
|---|
    1.16.3.1 | chlorpromazine |
formation of a complex with ceroluplasmin and stimulation. Good correlation of stability of enzyme-drug complex and electron donor ability of the drug molecule |
672518 |
| 1.16.3.1 | CuCl2 |
increase in enzyme mRNA due to transcriptional activation of enzyme geneยs promoter |
672774 |
| 1.16.3.1 | Iron |
an iron deficient diet fed over 12 months increases expression of enterocyte hephaestin |
696600 |
| 1.16.3.1 | Iron |
an iron overload diet fed over 6 months increases expression of ferritin in liver and enterocytes |
696600 |
| 1.16.3.1 | lactoferrin |
apolactoferrin increases the oxidation rate of Fe(II) by ceruloplasmin 1.25fold at pH 5.5. Lactoferrin saturated with Fe3+ or Cu2+ increases the oxidation rate of Fe2+ 1.6fold when in 1:1 ratio with enzyme |
672289 |
| 1.16.3.1 | lactoferrin |
enhances the ferroxidase activity of ceruloplasmin |
744470 |
| 1.16.3.1 | levopromazine |
formation of a complex with ceroluplasmin and stimulation. Good correlation of stability of enzyme-drug complex and electron donor ability of the drug molecule |
672518 |
| 1.16.3.1 | promazine |
formation of a complex with ceroluplasmin and stimulation. Good correlation of stability of enzyme-drug complex and electron donor ability of the drug molecule |
672518 |
| 1.16.3.1 | pyrrolidine dithiocarbamate |
regulation of ceruloplasmin expression by a copper-dependent transcriptional mechanism |
671888 |
| 1.16.3.1 | triflupromazine |
formation of a complex with ceroluplasmin and stimulation. Good correlation of stability of enzyme-drug complex and electron donor ability of the drug molecule |
672518 |
